Clinical trial Recruiting at 1 site Interventional Ages 45 to 64

Adapted Home Hazard Removal Program (HARP) for adults with physical disabilities

Official title: Adapting, Implementing and Evaluating the Effectiveness of the Home Hazard Removal Program for People With Disabilities

Run by Washington University School of Medicine · NCT07033897 · Data updated 2026-11-12

This pilot tests whether an adapted Home Hazard Removal Program (HARP) can reduce falls and improve home safety for community-dwelling adults aged 45–64 with long-term physical disabilities.

Quick facts

Study typeInterventional
Ages45 Years to 64 Years
SexAll
Enrollment80 (estimated)
SponsorWashington University School of Medicine
Academic / other
Locations1 site (St Louis, Missouri)
StatusRecruiting
StartedAugust 20, 2025
Main results expectedMarch 14, 2028
Study endsMarch 14, 2028
Registry record updatedNovember 4, 2026
Trial IDNCT07033897 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are community-dwelling adults aged 45–64 who have had a physical disability for at least five years, report difficulty with two or more daily activities, live in the City of St. Louis, and have had a fall in the past year or feel unsteady or worried about falling.

Probably not a fit

People who are institutionalized, those outside the 45–64 age range, those with a disability shorter than five years, or those without fall concerns or mobility limitations are unlikely to benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

The study uses a hybrid design combining a pilot randomized controlled trial and mixed-methods implementation work to adapt and test HARP for people with disabilities. Eighty participants will be single-blind randomized 1:1 to receive adapted HARP or be placed on a waitlist control, with monthly tracking of falls and fall-related injuries for 12 months. Fear of falling is measured at baseline and 12 months, and qualitative interviews and focus groups will inform adaptation and implementation planning guided by the RE-AIM framework. The trial will also collect data on types of home hazards, modifications made, and preliminary cost information to gauge feasibility and potential for wider dissemination.

Why it matters

Potential benefit: If successful, the adapted HARP could lower fall rates and fall-related injuries and help people with disabilities make their homes safer.

How similar studies have gone: Previous HARP work in older adults showed a 38% reduction in falls, but adapting HARP specifically for people with disabilities is a novel, pilot effort.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* age 45-64 years
* self-report of difficulty with ≥2 daily activities
* have had a physical disability for ≥5 years (e.g., spinal cord injury, cerebral palsy, post-polio syndrome, stroke, amputation)
* live in the City of St. Louis
* had a fall in the past year, or are worried about falling, or feel unsteady when standing or walking

Exclusion Criteria:

• individuals who are institutionalized

Where it's running

  • Washington University in St. Louis
    St Louis, Missouri, United States
    Recruiting

Study contacts

  • Principal investigator: Susan L Stark, PhD — Washington University School of Medicine
  • Study coordinator: Susan L Stark, PhD
  • Email: sstark@wustl.edu
  • Phone: (314)935-2551

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.